STOCK TITAN

Ligand Pharma (LGND) Net Income by Year

LGND

Ligand Pharma reported $124.5M in net income in fiscal year 2025. This represents an increase of 3186.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $197.2M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ligand Pharma has filed alongside them.

FY2025 annual
Net Income $124.5M
YoY +3186.6%
10Y CAGR -5.9%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LGND Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income$197.2M$124.5M+3186.6%-$4.0M-107.7%$52.2M+256.3%-$33.4M-158.4%$57.1M+2014.2%-$3.0M-100.5%$629.3M+339.1%$143.3M+1041.5%$12.6M+867.5%-$1.6M-100.7%$229.8M+1811.4%$12.0M+5.3%$11.4M+2267.0%-$527K-105.4%$9.7M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

LGND Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$48.5M+900.8%-$13.3M+68.6%$44.8M+244.1%$117.3M+1735.2%$4.8M+109.3%-$42.5M-149.3%-$31.1M-270.9%-$7.2M+30.2%-$51.9M-2366.9%$86.1M+105.3%$18.2M+204.0%-$10.3M-2642.8%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Ligand Pharma financials

Frequently Asked Questions

What was Ligand Pharma's net income in fiscal year 2025?

Ligand Pharma reported $124.5M in net income in fiscal year 2025.

How fast is Ligand Pharma's net income growing?

Ligand Pharma (LGND) net income rose by 3186.6% year over year, from -$4.0M to $124.5M in fiscal year 2025.

What is Ligand Pharma's net income over the last twelve months?

Ligand Pharma (LGND) reported $197.2M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Ligand Pharma (LGND) net income went from $9.7M in fiscal year 2011 to $124.5M in fiscal year 2025.

Ligand Pharma (LGND) reported $48.5M in net income in Q2 2026. This represents an increase of 900.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Ligand Pharma (LGND) reported on that line in every period on record.